Immunotherapy advances in pleural mesothelioma
Therapeutic Advances in Medical Oncology
Published online on February 13, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Mesothelioma is a rare cancer that carries a poor prognosis. This malignancy has had few therapeutic advances prior to the introduction of immune checkpoint inhibitors. Immunotherapy is now a cornerstone of first-line treatment for pleural mesothelioma ...
Mesothelioma is a rare cancer that carries a poor prognosis. This malignancy has had few therapeutic advances prior to the introduction of immune checkpoint inhibitors. Immunotherapy is now a cornerstone of first-line treatment for pleural mesothelioma ...